Research Papers

25 of 107 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatmen…
Yan R; Marshall T; Khullar A; Nagle T; Knowles J; Malkin M; Chubbs B; Swainson J.
Ther Adv Psychopharmacol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Drug safety in older patients with alcohol use disorder: a retrospective cohort study.
Schröder S; Westhoff MS; Pfister T; Seifert J; Bleich S; Koop F; Proskynitopoulos PJ; Glahn A; Heck J.
Ther Adv Psychopharmacol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Patients' awareness of recovery mediates the link between clinical and level of functional remission in schizophrenia t…
Mallet J; Dondé C; Dubertret C; Gorwood P.
Ther Adv Psychopharmacol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first epi…
Patel R; Brinn A; Irving J; Chaturvedi J; Gudiseva S; Correll CU; Fusar-Poli P; McGuire P.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Psychosocial interventions to improve adherence in depressed and anxious older adults prescribed antidepressant pharmac…
Stahl ST; Kincman J; Karp JF; Anne Gebara M.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness.
Koomen L; van de Meent I; Elferink F; Wilting I; Cahn W.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhag…
Høgnason Mohr G; Barcella CA; Grand MK; Kriegbaum M; Siersma V; Hahn MK; Agarwal SM; Bakkedal C; Baandrup L; Knop FK; Andersen CL; Ebdrup BH.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Optimizing treatment for older adults with depression.
Srifuengfung M; Pennington BRT; Lenze EJ.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction:…
Zhou N; Chen C; Liu Y; Yu Z; Chen Y.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications.
Zheng C; Liu H; Tu W; Lin L; Xu H.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Ketamine for bipolar depression: an updated systematic review.
Fancy F; Haikazian S; Johnson DE; Chen-Li DCJ; Levinta A; Husain MI; Mansur RB; Rosenblat JD.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interva…
O'Neill JR; Taylor DM; Horowitz MA.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The past, present and future of anticholinergic drugs.
Healy D.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Managing medical and psychiatric multimorbidity in older patients.
Carlson DM; Yarns BC.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Altered whole-brain resting-state functional connectivity and brain network topology in typhoon-related post-traumatic …
Chen HJ; Ke J; Qiu J; Xu Q; Zhong Y; Lu GM; Wu Y; Qi R; Chen F.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.
Evens R; Schmidt ME; Majić T; Schmidt TT.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketam…
Tsang VWL; Tao B; Dames S; Walsh Z; Kryskow P.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
High-dose olanzapine in treatment-resistant schizophrenia: a systematic review.
Gannon L; Reynolds J; Mahon M; Gaughran F; Lally J.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia.
Qubad M; Bittner RA.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies.
Bartoli F; Cavaleri D; Nasti C; Palpella D; Guzzi P; Riboldi I; Crocamo C; Pappa S; Carrà G.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment…
Gallo AT; Addis S; Martyn V; Ramanathan H; Wilkerson GK; Bennett KS; Hood SD; Stampfer H; Hulse GK.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Olanzapine for the treatment of ICU delirium: a systematic review and meta-analysis.
Liu SB; Liu S; Gao K; Wu GZ; Zu G; Jie Liu J.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Serum cytokine variations among inpatients with major depression, bipolar disorder, and schizophrenia <i>versus</i> hea…
Schmitt Junior AA; Primo de Carvalho Alves L; Padilha BL; da Rocha NS.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review.
Jollant F; Colle R; Nguyen TML; Corruble E; Gardier AM; Walter M; Abbar M; Wagner G.
Ther Adv Psychopharmacol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidence.
Oloyede E; Mantell B; Williams J; Lai S; Jauhar S; Taylor D; MacCabe JH; Harland R; McGuire P; Blackman G.
Ther Adv Psychopharmacol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared